The patent covers the use of ISC-hpNSC®, ISCO’s proprietary neural stem cells derived from human parthenogenetic stem cells, for the treatment of neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease and amyotrophic lateral sclerosis. This patent also covers the use of neural cells derived from other human pluripotent stem cell sources, such as human embryonic stem cells (hESC) and induced pluripotent stem (iPS) cells.
International Stem Cell Corporation Grant... - Cure Parkinson's
International Stem Cell Corporation Granted Key US Patent Protecting Lead Therapeutic Program

Written by

Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
I found the title, but I can't find the patent itself:
US10039794 - Use of neural cells derived from human pluripotent stem cells for the treatment of human neurodegenerative diseases.
Anyone else have more luck?
For anyone who might like some background information:
globenewswire.com/news-rele...
(this news release contains a link to a research paper)
Not what you're looking for?
You may also like...
More Stem Cell Success!
A new therapeutic approach in which patient-derived dopamine-producing neurons are transplanted...
Method generates dopaminergic neurons lost in Parkinson’s disease
"Forget The Mice, Just Fast Track for Patients".
Mice the winners again.
Researchers in Canada...
New Hope for Treatment of Parkinson’s Disease: Designer Neurons
"The new research describes the implantation of induced pluripotent stem cells (iPSCs) to replace...
Dopamine Neuron Implants Ease Parkinson’s Symptoms
Researchers in China have taken cell therapy for Parkinson’s disease one step further. In research...
How stem cell therapies actually 'work'
.... and how stem cell-derived treatments in the near future will not actually involve injecting...